Dual role for myosin II in GLUT4-mediated glucose uptake in 3T3-L1 adipocytes.
Insulin-stimulated glucose uptake requires the activation of several signaling pathways to mediate the translocation and fusion of GLUT4 vesicles to the plasma membrane. Our previous studies demonstrated that GLUT4-mediated glucose uptake is a myosin II-dependent process in adipocytes. The experiments described in this report are the first to show a dual role for the myosin IIA isoform specifically in regulating insulin-stimulated glucose uptake in adipocytes. We demonstrate that inhibition of MLCK but not RhoK results in impaired insulin-stimulated glucose uptake. Furthermore, our studies show that insulin specifically stimulates the phosphorylation of the RLC associated with the myosin IIA isoform via MLCK. In time course experiments, we determined that GLUT4 translocates to the plasma membrane prior to myosin IIA recruitment. We further show that recruitment of myosin IIA to the plasma membrane requires that myosin IIA be activated via phosphorylation of the RLC by MLCK. Our findings also reveal that myosin II is required for proper GLUT4-vesicle fusion at the plasma membrane. We show that once at the plasma membrane, myosin II is involved in regulating the intrinsic activity of GLUT4 after insulin stimulation. Collectively, our results are the first to reveal that myosin IIA plays a critical role in mediating insulin-stimulated glucose uptake in 3T3-LI adipocytes, via both GLUT4 vesicle fusion at the plasma membrane and GLUT4 activity.
Fulcher
F Kent
FK
Department of Biology, University of North Carolina at Greensboro, Greensboro, North Carolina 27402, USA.
Smith
Bethany T
BT
Russ
Misty
M
Patel
Yashomati M
YM
D041721:3T3-L1 Cells / Q000378:metabolism*; D017667:Adipocytes / Q000166:cytology / Q000502:physiology*; D000818:Animals; D001381:Azepines / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D051275:Glucose Transporter Type 4 / Q000235:genetics / Q000378:metabolism*; D006576:Heterocyclic Compounds, 4 or More Rings / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D008561:Membrane Fusion / Q000502:physiology; D051379:Mice; D024462:Myosin Type II / Q000235:genetics / Q000378:metabolism*; D009219:Myosin-Light-Chain Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009281:Naphthalenes / Q000378:metabolism; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
D001381:Azepines; D004791:Enzyme Inhibitors; D051275:Glucose Transporter Type 4; D006576:Heterocyclic Compounds, 4 or More Rings; D007328:Insulin; D009281:Naphthalenes; D020033:Protein Isoforms; C495693:Slc2a4 protein, mouse; C070571:ML 7; C472645:blebbistatin; D009219:Myosin-Light-Chain Kinase; D024462:Myosin Type II; D005947:Glucose
J Biol Chem. 1999 Nov 12;274(46):33085-91
10551878
Biochim Biophys Acta. 2001 Mar 15;1525(3):245-61
11257438
Nat Struct Mol Biol. 2005 Apr;12(4):378-9
15750603
Biochem Biophys Res Commun. 2005 Jun 17;331(4):1560-5
15883051
Curr Opin Cell Biol. 1999 Feb;11(1):26-33
10047526
J Muscle Res Cell Motil. 2002;23(7-8):719-27
12952070
Science. 1988 Feb 19;239(4842):883-8
3277283
Microsc Res Tech. 1999 Oct 15;47(2):79-92
10523787
J Neurochem. 2008 Apr;105(1):113-26
18005226
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1472-7
15671182
Breast Cancer Res Treat. 2004 May;85(2):103-10
15111768
Am J Physiol Cell Physiol. 2006 Nov;291(5):C860-8
16774991
J Biol Chem. 2005 Dec 23;280(51):42300-6
16239226
Biochim Biophys Acta. 2003 Aug 18;1641(2-3):175-81
12914958
Nature. 1970 Aug 15;227(5259):680-5
5432063
FEBS Lett. 2001 Dec 14;509(3):365-9
11749957
J Cell Sci. 2003 Sep 15;116(Pt 18):3761-70
12890752
Cancer Res. 2006 May 1;66(9):4725-33
16651425
Science. 2003 Mar 14;299(5613):1743-7
12637748
J Biol Chem. 2000 Dec 8;275(49):38151-9
10950952
Acta Physiol Scand. 1998 Dec;164(4):483-93
9887971
Exp Cell Res. 2005 Apr 1;304(2):506-17
15748895
Biochem J. 2001 Nov 1;359(Pt 3):639-49
11672439
Nature. 2002 Dec 19-26;420(6917):821-4
12490950
Mol Biol Cell. 2001 Jan;12(1):129-41
11160828
J Biol Chem. 2004 Aug 20;279(34):35557-63
15205456
J Biol Chem. 2002 Dec 27;277(52):50386-95
12393894
Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E758-66
15172888
J Biol Chem. 2004 Jun 25;279(26):27450-7
15069078
J Cell Sci. 1998 Aug;111 ( Pt 15):2085-95
9664030
J Biol Chem. 2001 Nov 9;276(45):42436-44
11546823
J Biol Chem. 2001 Feb 16;276(7):4527-30
11096123
Mol Cell Biol. 2007 Jul;27(14):5172-83
17515613
Endocrinology. 2005 Dec;146(12):5071-8
16150904
Exp Mol Med. 2006 Apr 30;38(2):180-9
16672772
Am J Physiol Cell Physiol. 2003 Sep;285(3):C662-73
12724136
Dev Cell. 2007 Sep;13(3):391-404
17765682
J Muscle Res Cell Motil. 2004;25(4-5):337-41
15548862
Biochem J. 2003 Dec 15;376(Pt 3):625-32
12974673
Calcif Tissue Int. 2002 Dec;71(6):530-8
12232674
Acta Physiol Scand. 2003 Aug;178(4):287-96
12864733
Endocr Rev. 2004 Apr;25(2):177-204
15082519
J Cell Biochem. 1998 Mar 1;68(3):389-401
9518264
Mol Biol Cell. 2004 Feb;15(2):688-95
14617807